Skip to main page content
U.S. flag

An official website of the United States government

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Search Results

15,440 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
The Unusual Mesophases and Properties Exhibited by a Family of Glycosteroids.
Cowling SJ, Queneau Y, Goodby JW, Ali-Rachedi F, Xavier NM, Chambert S, Zeng X, Abbott LC, Moore JN, Liu F, Yue X. Cowling SJ, et al. Among authors: zeng x. Chemistry. 2025 Jan 17:e202403678. doi: 10.1002/chem.202403678. Online ahead of print. Chemistry. 2025. PMID: 39821943
Lerociclib plus fulvestrant in patients with HR+/HER2- locally advanced or metastatic breast cancer who have progressed on prior endocrine therapy: LEONARDA-1 a phase III randomized trial.
Xu B, Zhang Q, Luo Y, Tong Z, Sun T, Shan C, Liu X, Yao Y, Zhao B, Wang S, Zeng X, Hu C, Yan X, Wang X, Jia H, Chen Z, Qiu F, Wu X, Zhang D, Li T. Xu B, et al. Among authors: zeng x. Nat Commun. 2025 Jan 16;16(1):716. doi: 10.1038/s41467-025-56096-2. Nat Commun. 2025. PMID: 39820749 Clinical Trial.
15,440 results
You have reached the last available page of results. Please see the User Guide for more information.